EMERCE, E. Et Al. 2014. A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity. The FEBS EMBO 2014 Conference , (Paris, France), 251.

EMERCE, E., ÇOK, İ., & DEĞİM, İ. T., (2014). A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity . The FEBS EMBO 2014 Conference (pp.251). Paris, France

EMERCE, ESRA, İSMET ÇOK, And İSMAİL TUNCER DEĞİM. "A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity," The FEBS EMBO 2014 Conference, Paris, France, 2014

EMERCE, ESRA Et Al. "A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity." The FEBS EMBO 2014 Conference , Paris, France, pp.251, 2014

EMERCE, E. ÇOK, İ. And DEĞİM, İ. T. (2014) . "A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity." The FEBS EMBO 2014 Conference , Paris, France, p.251.

@conferencepaper{conferencepaper, author={ESRA EMERCE Et Al. }, title={A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity}, congress name={The FEBS EMBO 2014 Conference}, city={Paris}, country={France}, year={2014}, pages={251} }